Cardiology Research and Practice

Research Article

Cardiovascular Risk Assessment in a Cohort of Newly Diagnosed Patients with Obstructive Sleep Apnea Syndrome

Table 4

Association between Systematic Coronary Risk Evaluation (SCORE), Framingham Risk Score (FRS), and anthropometric and sleep parameters.


	SCORE		FRS
	r		r

Age	0.652	<0.001	0.233	<0.001
BMI	−0.043	0.454	0.133	0.019
Neck circumference	−0.012	0.870	0.072	0.336
Waist circumference	−0.035	0.638	−0.029	0.701
Hip circumference	−0.061	0.417	−0.103	0.166
WHR	0.047	0.525	0.131	0.077
TST	−0.054	0.509	−0.188	0.021
N1	−0.007	0.927	0.035	0.668
N2	−0.007	0.933	0.028	0.732
N3	0.070	0.394	0.033	0.684
REM	−0.031	0.706	−0.122	0.135
AHI	0.251	<0.001	0.291	<0.001
ODI	0.049	0.661	−0.129	0.245
Aver. SpO₂	0.131	0.107	0.132	0.104
Min. SpO₂	0.127	0.119	0.143	0.102
Arousal index	−0.072	0.380	−0.127	0.122
Sleep efficiency	−0.073	0.372	−0.224	0.006
ESS score	0.103	0.156	0.108	0.135

AHI: apnoea hypopnea index; Aver. SpO₂: average oxyhaemoglobin saturation; BMI: body mass index; ESS: Epworth sleepiness scale; Min. SpO₂: minimum oxyhaemoglobin saturation; N1: sleep stage 1; N2: sleep stage 2; N3: sleep stage 3; ODI: oxygen desaturation index; REM: rapid eye movement; TST: total sleep time; WHR: waist to hip ratio.